Surgical management of inverted papilloma: approaching a new standard for surgery

Filippo Carta1, Jean-Philippe Blancal, Benjamin Verillaud

  • 1Assistance Publique-Hôpitaux de Paris, Department of Ear, Nose and Throat, Hôpital Lariboisière, Université Paris-Diderot, Paris, France.

Head & Neck
|September 25, 2012
PubMed
Abstract

Insights

Transnasal endoscopic surgery for inverted papilloma shows a low recurrence rate of 3.3%. This minimally invasive approach confirms recent findings and supports its use in managing inverted papilloma effectively.

Area of Science:

  • Otolaryngology
  • Surgical Oncology

Background:

  • Endoscopic surgery for inverted papilloma has a historical recurrence rate of 12%.
  • A recent strategy utilizing subperiosteal dissection reported a 5% recurrence rate.
  • Limited indications for external approaches were noted in prior studies.

Purpose of the Study:

  • To evaluate the reproducibility of excellent results reported for inverted papilloma surgery.
  • To assess if different surgical teams could achieve similar outcomes using established endoscopic concepts.

Main Methods:

  • Retrospective chart review of 71 consecutive inverted papilloma patients.
  • Analysis of treatment outcomes over a 10-year period.
  • Focus on patients treated with transnasal endoscopic surgery.

Main Results:

  • 80% of patients underwent a purely endoscopic surgical approach.
  • The mean follow-up duration was 31.6 months.
  • A recurrence rate of 3.3% was observed in patients with at least a 12-month follow-up.

Conclusions:

  • The study confirms excellent outcomes previously reported in literature for inverted papilloma management.
  • Transnasal endoscopic surgery is further supported as a primary treatment modality.
  • Minimally invasive endoscopic techniques demonstrate efficacy in reducing recurrence rates.